Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

More on the gastrointestinal safety of the specific COX-2 inhibitor valdecoxib

June 26, 2002

Good safety and efficacy profiles reported for adalimumab in Stockholm

June 26, 2002

BIM-51077, a stable GLP-1 analogue, shows potential in the management of type 2 diabetes

June 26, 2002

BVT-2733 tested in three animal models of type 2 diabetes

June 26, 2002

ENDO 2002 presentations discuss preclinical findings for rexinoid LG-100268

June 26, 2002

Proof of principle for orally active CCKA agonist GI-181771X

June 26, 2002

Potent HDAC inhibitors identified at Abbott with submicromolar antitumor activity

June 26, 2002

Transdermal administration of basal insulin through micropores for type 2 diabetes

June 25, 2002

Use of the Aerodose inhaler in type 2 diabetic patients

June 25, 2002

Both type 1 and 2 diabetics may benefit from Exubera according to phase III data

June 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...